Paper797498
Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications.
Klotz U. Clin Pharmacokinet, 1976. Cited by 67 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications. Papers, record 797498. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/797498
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pharmaceutical Preparations | Major topic |
| Adult | |
| Aged | |
| Aging | |
| Blood Proteins | |
| Body Surface Area | |
| Body Weight | |
| Child | |
| Drug Interactions | |
| Female | |
| Heart Diseases | |
| Hemodynamics | |
| Humans | |
| Infant | |
| Infant, Newborn | |
| Kidney Diseases | |
| Kinetics | |
| Liver Diseases | |
| Male | |
| Models, Biological | |
| Obesity | |
| Protein Binding | |
| Sex Factors | |
| Stress, Physiological | |
| Thyroid Gland |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,989,882 | Investigating Drug-Induced Thyroid Dysfunction Adverse Events Associated With Non-Selective RET Multi-Kinase Inhibitors: A Pharmacovigilance Analysis Utilizing FDA Adverse Event Reporting System Data. | Clin Epidemiol | 2025 | https://conductscience.org/library/papers/39989882 | PubMed |
| 36,836,174 | Considerations for Intravenous Anesthesia Dose in Obese Children: Understanding PKPD. | J Clin Med | 2023 | https://conductscience.org/library/papers/36836174 | PubMed |
| 29,950,704 | In-vivo topical mucosal delivery of a fluorescent deoxy-glucose delineates neoplasia from normal in a preclinical model of oral epithelial neoplasia. | Sci Rep | 2018 | https://conductscience.org/library/papers/29950704 | PubMed |
| 24,307,488 | Pooled population pharmacokinetic analysis of phase I, II and III studies of linifanib in cancer patients. | Clin Pharmacokinet | 2014 | https://conductscience.org/library/papers/24307488 | PubMed |
| 22,034,399 | Sex-dependent modulation of treatment response. | Dialogues Clin Neurosci | 2004 | https://conductscience.org/library/papers/22034399 | PubMed |
| 9,195,117 | Cyclosporin pharmacokinetics in paediatric transplant recipients. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9195117 | PubMed |
| 8,827,399 | Influence of diet and nutritional status on drug metabolism. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/8827399 | PubMed |
| 7,398,682 | Binding of tienilic acid (Diflurex) to human serum albumin and to plasma of normal subjects and uraemic patients. | Eur J Drug Metab Pharmacokinet | 1980 | https://conductscience.org/library/papers/7398682 | PubMed |
| 7,306,428 | Gallamine disposition in surgical patients with chronic renal failure. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7306428 | PubMed |
| 7,259,929 | Plasma protein binding of azapropazone in patients with kidney and liver disease. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7259929 | PubMed |
| 7,126,415 | Altered disposition and availability of cimetidine in liver cirrhotic patients. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7126415 | PubMed |
| 6,988,197 | The pharmacological role of the kidney. | Drugs | 1980 | https://conductscience.org/library/papers/6988197 | PubMed |
| 6,628,521 | The influence of uremia on the accessibility of phosphomycin into interstitial tissue fluid. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6628521 | PubMed |
| 6,340,904 | Clinical pharmacokinetics of metronidazole. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6340904 | PubMed |
| 6,156,048 | Disease-induced changes in the plasma binding of basic drugs. | Clin Pharmacokinet | 1980 | https://conductscience.org/library/papers/6156048 | PubMed |
| 3,924,086 | Comparative pharmacodynamics and clinical pharmacokinetics of phenoxymethylpenicillin and pheneticillin. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3924086 | PubMed |
| 3,293,870 | The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3293870 | PubMed |
| 3,011,046 | Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3011046 | PubMed |
| 2,886,244 | Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/2886244 | PubMed |
| 2,864,155 | Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. | Clin Pharmacokinet | 1985 | https://conductscience.org/library/papers/2864155 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/797498
GET https://conductscience.org/api/papers/v1/797498/cited_by?page=2